Medical News

RSS

Clinical data on simeprevir for treatment of hepatitis C patients to be presented at EASL meeting

Medivir AB today announces that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of genotype 1 hepatitis C patients.

23 Apr 2013

Study: Primary care density correlated with lung cancer mortality in white population

Lung cancer remains the leading cause of cancer-related deaths and is tied as the third leading cause of death overall in industrialized countries. Within the United States, several groups identified by race, sex, and socioeconomic status have been linked to increased cancer mortality, suggesting a disparity because of these characteristics.

23 Apr 2013

World must be better prepared for potential pandemics

"In China an influenza virus never before seen in people had, as The Economist went to press, infected at least 82 and killed 17. Meanwhile a new type of coronavirus, the family that brought severe acute respiratory syndrome (SARS), is festering in the Middle East," an editorial in the magazine states.

23 Apr 2013

Study: Atrophy in an important area of brain predicts multiple sclerosis

Magnetic resonance imaging (MRI) measurements of atrophy in an important area of the brain are an accurate predictor of multiple sclerosis (MS), according to a new study published online in the journal Radiology.

23 Apr 2013

Research: Skin's immune cell plays a role in fighting off parasitic invaders

Sydney researchers have discovered a new type of immune cell in skin that plays a role in fighting off parasitic invaders such as ticks, mites, and worms, and could be linked to eczema and allergic skin diseases.

23 Apr 2013

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Pharma, S.A., today announced the European launch of Pliaglis (lidocaine and tetracaine) Cream 7%/7%.

23 Apr 2013

Consuming grapes may protect against organ damage associated with metabolic syndrome

Consuming grapes may help protect against organ damage associated with the progression of metabolic syndrome, according to research presented Monday at the Experimental Biology conference in Boston. Natural components found in grapes, known as polyphenols, are thought to be responsible for these beneficial effects.

23 Apr 2013

Study: About 42% of screened veterans with blast injuries have irregular hormone levels

Up to 20 percent of veterans returning from Afghanistan and Iraq have experienced at least one blast concussion. New research suggests that nearly half these veterans may have a problem so under-recognized that even military physicians may fail to look for it.

23 Apr 2013

RUSM students to perform clinical training at Vanguard MacNeal Hospital

Ross University School of Medicine announced an agreement with Vanguard MacNeal Hospital in Berwyn, Ill. which enables RUSM students to perform clinical training in the Chicago-area teaching hospital.

23 Apr 2013

Senate immigration bill could boost healthcare workforce

News outlets report that the plan could make it easier for foreign-born doctors to come to the United States while reducing the dependence of newly legal immigrants on emergency rooms.

23 Apr 2013

Theradiag obtains CE mark for proprietary anti-CCP IVD kit in rheumatoid arthritis

Theradiag, a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for its proprietary anti-CCP in vitro diagnostic kit in rheumatoid arthritis.

23 Apr 2013

Health experts are turning to HIA to predict the effects of gas drilling on local communities

As natural gas development expands nationwide, policymakers, communities and public health experts are increasingly turning to health impact assessments (HIA) as a means of predicting the effects of drilling on local communities, according to a new study from the Colorado School of Public Health.

23 Apr 2013

Experimental drug can reduce breast-cancer aggressiveness, restore drug-sensitivity

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.

23 Apr 2013

First Edition: April 23, 2013

Today's headlines include reports about immigrant patients' health care as well as the coverage limits that some victims of the Boston Marathon bombings might face.

23 Apr 2013

New screening method detects ovarian cancer by examining neighboring cells

Pioneering biophotonics technology developed at Northwestern University is the first screening method to detect the early presence of ovarian cancer in humans by examining cells easily brushed from the neighboring cervix or uterus, not the ovaries themselves.

23 Apr 2013

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.

23 Apr 2013

Exposure to chemical pesticide has impacts that span multiple generations, say researchers

North Carolina State University researchers studying aquatic organisms called Daphnia have found that exposure to a chemical pesticide has impacts that span multiple generations - causing the so-called "water fleas" to produce more male offspring, and causing reproductive problems in female offspring.

23 Apr 2013

Medical News

Clinical data on simeprevir for treatment of hepatitis C patients to be presented at EASL meeting

Study: Primary care density correlated with lung cancer mortality in white population

World must be better prepared for potential pandemics

Study: Atrophy in an important area of brain predicts multiple sclerosis

Research: Skin's immune cell plays a role in fighting off parasitic invaders

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Consuming grapes may protect against organ damage associated with metabolic syndrome

Study: About 42% of screened veterans with blast injuries have irregular hormone levels

RUSM students to perform clinical training at Vanguard MacNeal Hospital

Senate immigration bill could boost healthcare workforce

Theradiag obtains CE mark for proprietary anti-CCP IVD kit in rheumatoid arthritis

Health experts are turning to HIA to predict the effects of gas drilling on local communities

Experimental drug can reduce breast-cancer aggressiveness, restore drug-sensitivity

First Edition: April 23, 2013

New screening method detects ovarian cancer by examining neighboring cells

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Exposure to chemical pesticide has impacts that span multiple generations, say researchers

Researchers find tumors with ALK rearrangements can harbor additional mutations

GeneCapture developing new device with one-hour pathogen testing capabilities

Sleep deprivation affects vascular function and impairs breathing control

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News